Related references
Note: Only part of the references are listed.MicroRNA regulation of progesterone receptor in breast cancer
Avital Gilam et al.
ONCOTARGET (2017)
Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer
K. Miyamoto et al.
BRITISH JOURNAL OF CANCER (2016)
miTALOS v2: Analyzing Tissue Specific microRNA Function
Martin Preusse et al.
PLOS ONE (2016)
Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges
Thomas McFall et al.
ONCOTARGET (2015)
Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy
Daisuke Nakada et al.
NATURE (2014)
Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2
Sheng Tan et al.
BREAST CANCER RESEARCH (2014)
Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells
Ndiya Ogba et al.
BREAST CANCER RESEARCH (2014)
Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer
Xiang H. -F. Zhang et al.
CLINICAL CANCER RESEARCH (2013)
Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer
Haiyan Si et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Womens Health Initiative Observational Study
Rowan T. Chlebowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
Gianpiero Di Leva et al.
PLOS GENETICS (2013)
Progesterone Decreases Levels of the Adhesion Protein E-Cadherin and Promotes Invasiveness of Steroid Receptor Positive Breast Cancers
Anastasia Kariagina et al.
HORMONES & CANCER (2013)
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2012)
MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility
Liang Zhu et al.
MEDICAL ONCOLOGY (2012)
Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration
Sofie Nilsson et al.
PLOS ONE (2012)
ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer
Irene K. Guttilla et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy A Randomized Controlled Trial
Andrea Z. LaCroix et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The Antiproliferative Action of Progesterone in Uterine Epithelium Is Mediated by Hand2
Quanxi Li et al.
SCIENCE (2011)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice
Yayun Liang et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth
Gerard Maillot et al.
CANCER RESEARCH (2009)
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells
Nalinie S. Wickramasinghe et al.
NUCLEIC ACIDS RESEARCH (2009)
Immunohistochemically Determined Estrogen Receptor Phenotype Remains Stable in Recurrent and Metastatic Breast Cancer
Carmen Gomez-Fernandez et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
miRiad roles for the miR-17-92 cluster in development and disease
Joshua T. Mendell
CELL (2008)
Progesterone receptor-B regulation of insulin-like growth factor - Stimulated cell migration in breast cancer cells via insulin receptor substrate-2
Yasir H. Ibrahim et al.
MOLECULAR CANCER RESEARCH (2008)
R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism
Aymen Shatnawi et al.
MOLECULAR ENDOCRINOLOGY (2007)
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
Lisa K. Dunnwald et al.
BREAST CANCER RESEARCH (2007)
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
O. A. Kent et al.
ONCOGENE (2006)
Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates
TA Hopp et al.
CLINICAL CANCER RESEARCH (2004)
Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle
JB Barnett et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women
SA Missmer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion
N Platet et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form A or B of the progesterone receptor and then treatment with progestins
T Sumida et al.
CANCER RESEARCH (2004)
Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells
JK Richer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis
PA Mote et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding
PH Giangrande et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
